tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

LXEO Stock Latest News

Lexeo Therapeutics reports ‘positive’ results from LX2006 study
The FlyLexeo Therapeutics reports ‘positive’ results from LX2006 study
7d ago
LXEO
Lexeo Therapeutics Announces Positive Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
PremiumPress Releases
Lexeo Therapeutics Announces Positive Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
7d ago
LXEO
Lexeo Therapeutics to report interim Phase 1/2 clinical data of LX2006
PremiumThe Fly
Lexeo Therapeutics to report interim Phase 1/2 clinical data of LX2006
11d ago
LXEO
Lexeo Therapeutics Welcomes New Board Member Tim Van Hauwermeiren
PremiumCompany Announcements
Lexeo Therapeutics Welcomes New Board Member Tim Van Hauwermeiren
14d ago
8K
LXEO
Lexeo Therapeutics appoints Tim Van Hauwermeiren to board of directors
PremiumThe Fly
Lexeo Therapeutics appoints Tim Van Hauwermeiren to board of directors
14d ago
ARGX
LXEO
Lexeo Therapeutics Appoints Tim Van Hauwermeiren to its Board of Directors
PremiumPress ReleasesLexeo Therapeutics Appoints Tim Van Hauwermeiren to its Board of Directors
14d ago
LXEO
Lexeo Therapeutics initiated with an Outperform at Baird
PremiumThe Fly
Lexeo Therapeutics initiated with an Outperform at Baird
1M ago
LXEO
Lexeo Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Lexeo Therapeutics initiated with a Buy at H.C. Wainwright
2M ago
LXEO
Lexeo sees cash, equivalents sufficient to fund operations into 2027
PremiumThe Fly
Lexeo sees cash, equivalents sufficient to fund operations into 2027
2M ago
LXEO
Lexeo Therapeutics reports Q1 EPS (77c), consensus (77c)
PremiumThe Fly
Lexeo Therapeutics reports Q1 EPS (77c), consensus (77c)
2M ago
LXEO
Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights
PremiumPress Releases
Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights
2M ago
LXEO
Lexeo Therapeutics to Participate in Upcoming Investor Conferences
PremiumPress Releases
Lexeo Therapeutics to Participate in Upcoming Investor Conferences
3M ago
LXEO
Bernard Davitian to Exit Board of Lexeo Therapeutics
PremiumCompany AnnouncementsBernard Davitian to Exit Board of Lexeo Therapeutics
3M ago
8K
LXEO
Lexeo announces license agreement to accelerate development of LX2006
PremiumThe Fly
Lexeo announces license agreement to accelerate development of LX2006
3M ago
LXEO
Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
PremiumPress Releases
Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
3M ago
LXEO
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy
PremiumPress Releases
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy
3M ago
LXEO
Lexeo Therapeutics announces U.S. FDA granted FTD to LX2006
PremiumThe Fly
Lexeo Therapeutics announces U.S. FDA granted FTD to LX2006
3M ago
LXEO
Lexeo Therapeutics files to sell 6.97M shares of common stock for holders
PremiumThe Fly
Lexeo Therapeutics files to sell 6.97M shares of common stock for holders
3M ago
LXEO
Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing
PremiumPress Releases
Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing
4M ago
LXEO
Lexeo Therapeutics price target raised to $24 from $22 at RBC Capital
PremiumThe FlyLexeo Therapeutics price target raised to $24 from $22 at RBC Capital
4M ago
LXEO
Lexeo Therapeutics’ Strategic $95M Share Placement and Financial Update
PremiumCompany Announcements
Lexeo Therapeutics’ Strategic $95M Share Placement and Financial Update
4M ago
8K
LXEO
Lexeo Therapeutics reports protein expression data from SUNRISE-FA trial
PremiumThe Fly
Lexeo Therapeutics reports protein expression data from SUNRISE-FA trial
4M ago
LXEO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >